Cardiac Amyloidosis: Internist and Cardiologist Insight
Cardiac amyloidosis (amyloid cardiomyopathy) is a disease damage to the heart caused by extracellular amyloid deposition. In some cases, there may be local damage to the structures of the heart, for example, the atria; more often, heart damage is part of a systemic (generalized) pathology. Depending...
Main Authors: | E. V. Reznik, T. L. Nguyen, E. A. Stepanova, D. V. Ustyuzhanin, I. G. Nikitin |
---|---|
Format: | Article |
Language: | Russian |
Published: |
SINAPS LLC
2020-12-01
|
Series: | Архивъ внутренней медицины |
Subjects: | |
Online Access: | https://www.medarhive.ru/jour/article/view/1106 |
Similar Items
-
Retrospective analysis of cardiovascular involvement in patients with systemic amyloidosis
by: E. V. Reznik, et al.
Published: (2021-02-01) -
Atrial Fibrillation and Heart Failure as the Onset of AL-Amyloidosis
by: E. V. Reznik, et al.
Published: (2021-11-01) -
Modern echocardiographic criteria for heart failure with preserved ejection fraction: not only diastolic dysfunction
by: O. M. Drapkina, et al.
Published: (2020-04-01) -
Detection rate and characteristics of heart failure, depending on the diagnostic criteria in COVID-19 survivors one year after hospitalization
by: Yu. V. Mareev, et al.
Published: (2023-01-01) -
Antiarrhythmic therapy choice in patients with left ventricular diastolic dysfunction and atrial fibrillation
by: A. V. Tarasov, et al.
Published: (1970-01-01)